Pharming Group NV Share Price Today: Live Updates & Key Insights

Pharming Group NV share price today is $15.34, up -0.71%. The stock opened at $15.59 against the previous close of $15.47, with an intraday high of $15.71 and low of $15.44.

Pharming Group NV Share Price Chart

Pharming Group NV

us-stock
To Invest in {{usstockname}}
us-stock

Pharming Group NV Share Price Performance

$15.34 -0.0071(-0.71%) PHAR at 23 Mar 2026 02:44 PM Biotechnology
Lowest Today 15.44
Highest Today 15.71
Today’s Open 15.59
Prev. Close 15.47
52 Week High 21.34
52 Week Low 7.50
Day’s Range: Low 15.44 High 15.71
52-Week Range: Low 7.50 High 21.34
1 day return -
1 Week return -0.13
1 month return -8.13
3 month return -14.18
6 month return +2.83
1 year return +76.3
3 year return +50.99
5 year return +18.95
10 year return -

Pharming Group NV Institutional Holdings

Silverberg Bernstein Capital Management LLC 0.07

Goss Wealth Management LLC 0.04

Millennium Management LLC 0.03

Citadel Advisors Llc 0.03

SmartHarvest Portfolios, LLC 0.02

Morgan Stanley - Brokerage Accounts 0.01

Gestión Boutique VI Noax Global FI 0.00

Fidelity Nasdaq Composite Index 0.00

EverSource Wealth Advisors, LLC 0.00

Nalls Sherbakoff Group, LLC 0.00

BNP Paribas Arbitrage, SA 0.00

Global Retirement Partners, LLC. 0.00

Bessemer Group Inc 0.00

SBI Securities Co Ltd 0.00

Pharming Group NV Market Status

Strong Buy: 2

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Pharming Group NV Fundamentals

Market Cap 1070.11 M

PB Ratio 3.8568

PE Ratio 384.0

Enterprise Value 1035.15 M

Total Assets 425.52 M

Volume 21682

Pharming Group NV Company Financials

Annual Revenue FY23:218720000 218.7M, FY22:205622000 205.6M, FY21:189853038 189.9M, FY20:228394667 228.4M, FY19:189333722 189.3M

Annual Profit FY23:194353000 194.4M, FY22:188060000 188.1M, FY21:169670071 169.7M, FY20:203056430 203.1M, FY19:165412447 165.4M

Annual Net worth FY23:-22055000 -22.1M, FY22:13674000 13.7M, FY21:15271393 15.3M, FY20:40631457 40.6M, FY19:40544628 40.5M

Quarterly Revenue Q3/2025:97287000 97.3M, Q2/2025:93221000 93.2M, Q1/2025:79094000 79.1M, Q3/2024:75062600 75.1M, Q2/2024:74030646 74.0M

Quarterly Profit Q3/2025:90216000 90.2M, Q2/2025:84249000 84.2M, Q1/2025:70771000 70.8M, Q3/2024:68224141 68.2M, Q2/2024:66038134 66.0M

Quarterly Net worth Q3/2025:7548000 7.5M, Q2/2025:4694000 4.7M, Q1/2025:-14719000 -14.7M, Q3/2024:-1034000 -1.0M, Q2/2024:-1198876 -1.2M

About Pharming Group NV & investment objective

Company Information Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. It has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Organisation Biotechnology

Employees 404

Industry Biotechnology

CEO Mr. Fabrice Chouraqui Ph.D., Pharm.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Pharming Group NV FAQs

What is the share price of Pharming Group NV today?

The current share price of Pharming Group NV is $15.34.

Can I buy Pharming Group NV shares in India?

Yes, Indian investors can buy Pharming Group NV shares by opening an international trading and demat account with Motilal Oswal.

How to buy Pharming Group NV shares in India?

You can easily invest in Pharming Group NV shares from India by:

Can I buy fractional shares of Pharming Group NV?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Pharming Group NV?

Pharming Group NV has a market cap of $1070.11 M.

In which sector does Pharming Group NV belong?

Pharming Group NV operates in the Biotechnology sector.

What documents are required to invest in Pharming Group NV stocks?

To invest, you typically need:

What is the PE and PB ratio of Pharming Group NV?

The PE ratio of Pharming Group NV is 384.00 and the PB ratio is 3.86.